secwatch.observer — SEC 8-K summary
======================================

Issuer:     Perspective Therapeutics, Inc. (CATX)
CIK:        0000728387
Form:       8-K
Filed at:   2025-09-02T23:59:59+00:00
Accession:  0000728387-25-000006
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Perspective Therapeutics updates corporate presentation; no material new information disclosed
--------------------------------------------------------------------------------

- Filing reports updated corporate presentation as Exhibit 99.1, but no specific new data or milestones are mentioned.
- Presentation covers 212Pb radiopharmaceutical pipeline for neuroendocrine tumors and melanoma, and manufacturing supply chain.
- No financial results, guidance changes, or regulatory events are presented in the filing or exhibit.
- Updates appear to be routine corporate slides without substantive new disclosures for investors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/728387/000072838725000006/0000728387-25-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/728387/000072838725000006/catx-20250902.htm
  HTML page:      https://secwatch.observer/filing/0000728387-25-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer